Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the adult population
worldwide. This pathology can progress into end-stage liver disease with life-threatening …

Purpose Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease
that is driven by the metabolic syndrome. NAFLD encompasses nonalcoholic fatty liver,> 5 …

Nonalcoholic fatty liver disease (NAFLD) is recognized as the most common cause of
chronic liver disease worldwide. NAFLD is a clinicopathologic syndrome ranging from …

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of
chronic liver disease due to an increase in the prevalence of obesity. The development of …

Nonalcoholic fatty liver disease (NAFLD) represents a major public health epidemic.
Pharmacologic therapies for this condition are scarce, but multiple agents with novel …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
Western world (it affects 30% of the general adult population). The NAFLD encompasses a …

NAFLD is the most common chronic liver disease worldwide, occurring in both obese and
lean patients. It can lead to life-threatening liver diseases and nonhepatic complications …

Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease in
industrialized economies. With no licensed treatment currently available, together with a …

Purpose Nonalcoholic fatty liver disease (NAFLD), more recently referred to as metabolic-
associated fatty liver disease, refers to a disease spectrum ranging from hepatic steatosis to …

Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disorder in
Western countries and is increasingly being recognized in developing nations. Fatty liver …